Jeffrey Desantis, DPM
Foot & Ankle Surgery · Orange, CANPI 1659371748
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Averitas Pharma Inc. at 51.1% of the total. 2024 is the largest year on record at $4,290, more than ten times the $162 reported in 2019.
Across 49 payments — averaging $177.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Averitas Pharma Inc.$4K
- Heron Therapeutics, Inc.$2K
- IQ Med LLC$1K
- Treace Medical Concepts, Inc.$515
- Amgen$141
- Zimmer Biomet$131
- plus $508 from 14 others
Across 9 payments — averaging $12,083 each. An ownership or investment interest held by the physician or an immediate family member.
- GLW, Inc$109K
- IQ Med LLC$0
What the payments were for
- Consulting fees$1,40016%
- Speaking & faculty fees$3,22037%
- Travel & lodging$1,40916%
- Food & beverage$1,23614%
- Gifts$1,03912%
- Ownership interest$3734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Averitas Pharma Inc. | 15 | $4,434 |
| Heron Therapeutics, Inc. | 3 | $1,535 |
| IQ Med LLC | 3 | $1,412 |
| Treace Medical Concepts, Inc. | 4 | $515 |
| Amgen | 3 | $141 |
| Zimmer Biomet | 4 | $131 |
| Stryker | 3 | $108 |
| Novastep Inc. | 1 | $79 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $65 |
| Smith+Nephew | 2 | $37 |
| Kerecis Limited | 1 | $37 |
| Collaborative Care Diagnostics, LLC | 1 | $34 |
| Integra Lifesciences Corporation | 1 | $30 |
| Saxum Surgical, Inc. | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $23 |
| Medartis Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $16 |
| Acell, Inc. | 1 | $15 |
| Amniox Medical, Inc. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$4,271
- Zynrelef$1,521
- Lapiplasty System$495
- KRYSTEXXA$112
How this compares
$8,677 in reported general payments places this provider in the 80th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 20 | $336 |
| Clotrimazole | 32 | $321 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Orange
- Andrew HsuOrange$456K
- Brandon HaghverdianOrange$84K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Eric TanLos Angeles$447K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.